Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 by Roots Analysis

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious op            timism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.

 


Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent))”.

 

The  report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of companies engaged in the development of stem cell therapies for treatment of wide range of clinical conditions

§  Elaborate profiles of key industry players engaged in the development of stem cell therapies  (shortlisted on the basis of the product portfolio).

§  An insightful competitiveness analysis featuring a four-dimensional bubble chart, highlighting the key players in this domain.

§  An assessment of over 20 commonly targeted therapeutic areas and details of stem cell-based therapies being developed to treat the same conditions.

§  A detailed proprietary 2×2 representation that was developed to assess the current market scenario (in terms of existing competition and growth opportunities) across emerging and established market segments.

§  An in-depth analysis of more than 1,500 grants that have been awarded to research institutes engaged in stem cell therapy-related projects, in the period between 2015 and 2019 (till November)

§  A detailed clinical trial analysis on more than 540 completed, ongoing and planned studies of various stem cell therapies, highlighting prevalent trends across various relevant parameters.

§  A review of the key aspects related to the manufacturing of stem cell therapies, including [A] a detailed discussion on processes and protocols, highlighting the need to outsource various aspects of stem cell therapy development and manufacturing operations, [B] an assessment of the current market landscape of contract manufacturers, providing information on stem cell-focused service providers, and [C] an insightful Harvey ball analysis to identify the key performance indicators / key considerations that industry stakeholders are likely to take into consideration while selecting a suitable CMO / CRO partner.

§  A detailed market gap analysis in order to develop a realistic understanding of the demand and supply dynamics within this field, comparing both clinical and commercial capabilities of therapy developers and the availability and capabilities of contract manufacturers, across different geographies.

§  An elaborate discussion on the various strategies that can be adopted by stem cell therapy developers across different stages of product development and commercialization.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Source of Stem Cell

§  Allogeneic

§  Autologous

 

§  Origin of Stem Cell

§  Adult

§  Embryonic

 

§  Type of Stem Cell

§  Hematopoietic

§  Mesenchymal

§  Progenitor

§  Others

 

§  Lineage of Stem Cell

§  Adipose Tissue

§  Bone Marrow

§  Cord Blood

§  Others

 

To request for report - https://www.rootsanalysis.com/reports/296/request-sample.html

 

§  Route of Administration

§   Intraarticular

§   Intracoronary

§   Intramuscular

§   Intramyocardial

§   Intrathecal

§   Intravenous

§   Surgical Implantations

§   Others

 

§  Therapeutic Area

§  Autoimmune / Inflammatory Disorder

§  Cardiovascular Disorders

§  Metabolic Disorder

§  Musculoskeletal Disorders

§  Oncological Disorders

§  Neurological Disorders

§  Ophthalmic Disorders

§  Others

 

§  End Users

§  Ambulatory Surgery Centers

§  Hospitals

§  Specialty Clinics

 

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific and Rest of the World

 

 

Key companies covered in the report

§  Anterogen

§  Athersys

§  CHABiotech

§  Cytopeutics

§  Hope Biosciences

§  Japan Regenerative Medicine

§  Lineage Cell Therapeutics

§  Orchard Therapeutics

§  Osiris Therapeutics

§  Pluristem Therapeutics

§  Promithera Biosciences

§  Regenexx

§  Stempeutics Research

§  SCM Life Sciences

§  TICEBA

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/

 

Other Recent Offerings

1.     Stem Cell Therapy Contract Manufacturing Market, 2019-2030

2.     Antibody Drug Conjugates Market (5th Edition), 2019-2030

3.     Cell and Advanced Therapies Supply Chain Management Market, 2019-2030: Focus on Technological Solutions

4.     Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

 

Contact Details 

Ben Johnson 

+1 (415) 800 3415 

ben.johnson@rootsanalysis.com 

 

Roots Analysis 

Web: https://www.rootsanalysis.com/ 

LinkedIn: https://in.linkedin.com/company/roots-analysis 

Twitter: https://twitter.com/RootsAnalysis.com 

Medium: https://medium.com/@RootsAnalysis 

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/ 

Quora: https://rootsanalysisinsights.quora.com/ 

                                                                            

Comments

Post a Comment

Popular posts from this blog

The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers

Image
Several innovative drug delivery technologies have gathered notable momentum (in terms of adoption and sales) soon after entering the market; most of these are designed to address the unmet needs of administering complex pharmacological interventions Roots Analysis has announced the addition of the “ On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles ” report to its list of offerings.   Since the early 20th century, over 12,000 patents / patent applications have been granted / filed in relation to drug delivery devices that can either be worn on the body ( or implanted ), by both industry and non-industry players. Presently, innovation in this domain is focused on developing cheaper and more environment friendly drug delivery systems, with provisions to minimize / altogether eliminate the risk of needlestick injuries. ...
Read more

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

Image
To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html   Key Inclusions §   A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory),  type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), route of administration (intravenous, subcutaneous, oral and others), target disease indication, target therapeutic area and type of therapy (monotherapy, combination therapy and both).  §   A detailed analysis of more than 590 completed, ongoing and planned clinical studies of next generation immune checkpoint inhibitors and stimulators, highlighting prevalent trends across various relevant paramete...
Read more

The CAR-T cell therapy market is estimated to be worth USD 14 billion in 2030, predicts Roots Analysis

Image
  Given their ability to selectively direct a cell mediated immune response against cancer cells and, thereby, offer prolonged periods of disease remission, several CAR-T cell therapies are expected to achieve blockbuster status   Roots Analysis is pleased to announce the publication of its recent study, titled, “ CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Forecasts, 2021-2030 ”   The features an extensive study of the current market landscape and the future potential of CAR-T cell therapies. The report highlights the efforts of both industry players and acade...
Read more